Stock ESTA ESTABLISHMENT LABS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
43.23 USD -1.14% Intraday chart for Establishment Labs Holdings Inc. -4.86% +66.98%
Jul. 03 Establishment Labs Holdings Insider Sold Shares Worth $309,775, According to a Recent SEC Filing MT
Jun. 10 Transcript : Establishment Labs Holdings Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Establishment Labs Holdings Insider Sold Shares Worth $309,775, According to a Recent SEC Filing
MT
Findell Capital Management LLC Releases Comprehensive Research Coverage Report
AQ
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA: Nasdaq
AQ
Transcript : Establishment Labs Holdings Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
Mizuho Securities Raises Price Target on Establishment Labs to $70 From $65, Maintains Buy Rating
MT
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
BU
Citigroup Downgrades Establishment Labs Holdings to Neutral From Buy With $60 Price Target
MT
Transcript : Establishment Labs Holdings Inc., Q1 2024 Earnings Call, May 08, 2024
Establishment Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Posts Q1 Revenue $37.2M, vs. Street Est of $35.5M
MT
Establishment Labs Reports First Quarter 2024 Financial Results
BU
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024
CI
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
BU
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
BU
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
BU
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
BU
Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating
MT
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility
MT
Mizuho Securities Raiset Price Target on Establishment Labs to $65 From $50, Keeps Buy Rating
MT
TD Cowen Adjusts Establishment Labs Price Target to $60 From $50, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ESTA Stock
  4. News Establishment Labs Holdings Inc.